Kaundinya Gopinath1, Elissar Andari1, and Larry Young1
1Emory University, Atlanta, GA, United States
Synopsis
Autism spectrum disorders
(ASD) are characterized by dysregulation of endogenous oxytocin (OXT) function.
In this
study, we employed complexity of resting state fMRI signal as a tool to
examine: 1) brain function impairments in adult ASD, 2) the relationship
between DNA methylation of OXT receptor gene and severity of cognitive
impairment, and 3) the effects of intranasal OXT treatment (IN-OXT). ASD patients exhibited abnormally increased
fMRI signal complexity in a number of brain function networks. The severity of
these impairments were inversely related to DNA methylation levels. IN-OXT
attenuated impairments in these networks. Thus, OXT has neuroprotective effects
in ASD.
INTRODUCTION
Autism spectrum disorder
(ASD) is a neurodevelopmental disorder characterized by impairments in social
interactions and communication, as well as repetitive behaviors and restricted
interests 1. ASD is characterized by deficits in social cognition, face processing,
and emotional regulation functions 1-3. Dysregulation of endogenous oxytocin (OXT) function has been reported
in ASD 4, and its exogenous application was shown to enhance social
functioning in ASD 5. ASD is characterized by disruptions in the
brain’s excitation/inhibition (E/I) balance 6. OXT is also thought to enhance social cognition through its effects on
GABA mediated control of E/I balance 6. Recently, an fMRI time-series signal complexity metric, multi-scale entropy (MSE)
has been proposed as a potential biomarker of this E/I balance and neural
activity 7-9. In this study, we employed MSE of resting
state fMRI (rsfMRI) data to examine brain function impairments in ASD, and the
effects of intranasal OXT (IN-OXT) treatment on ASD. Finally, OXT acts through
the OXT receptor (OXTR) which is synthesized by the OXTR gene 10. The expression of
OXTR gene across the brain is influenced by DNA methylation of that gene 10. DNA methylation
levels of OXTR gene are an indication of endogenous OXT activity 10. Hence, we also investigated
the relationship between DNA methylation of the OXT receptor gene and brain
function impairments in ASD.METHODS
Thirty adult males with ASD (mean age ~ 29 years) were administered OXT and
placebo intranasally in separate MR imaging sessions, in a double-blind study. For
each ASD subject DNA methylation levels were obtained at six sites of the OXTR
gene that were most implicated in ASD 11. Then ASD subjects and 17 age matched healthy
controls (HC) who were not administered IN-OXT or placebo, were scanned in
a Siemens 3T MRI Prisma-Fit scanner using a 64-channel Rx head+neck coil.
Written informed consent was obtained from all participants in the protocol
approved by the local Institutional Review Board. RsfMRI data were acquired
with a 8-min whole-brain gradient echo EPI (TR/TE/FA = 3000ms/25ms/90°,
resolution = 1.5mm x 1.5mm x 2.4mm). RsfMRI preprocessing steps included
attenuation of signal related to subject-motion and physiological responses,
using the AROMA techniques 12,
spatial normalization to MNI152 space, and spatial smoothing with FWHM = 6mm
isotropic Gaussian kernel. For each voxel time-series, sample entropy (SE) was
calculated at 10 temporal scales using the Complexity toolbox 7,8,
with window-length to m = 2, and
distance threshold r = 0.3 (after
optimization of parameters7,8).
ROI-averaged MSEs were obtained from each brain resting state network (RSN)
estimated from 1) Group ICA of ASD subjects’ placebo scan and HC; and 2) Group
ICA of ASD subjects’ four fMRI scans at 48 IU, 24 IU, 8 IU doses of IN-OXT, and
placebo. Between-group, and between-session
differences in complexity were obtained with separate 2-sample (and paired)
t-tests on each ICA RSN’s ROI averaged MSE. The relationship between the
functional connectivity of each RSN with ASD subjects DNA methylation levels for
each OXTR gene site were assessed with multiple linear regression.RESULTS & DISCUSSION
ASD patients exhibited (Table 1) significantly
(FDR q < 0.05) abnormally increased
SE compared to HC at longer temporal scales (5-10) in a number RSNs including
social cognition, reward processing, limbic, attention, executive function,
sensorimotor, and higher order visual processing networks. This is consistent
with deficits in these functions seen in ASD 13-16. The abnormally
increased complexity in these brain function networks could reflect increased
synaptic noise arising from synaptic pruning deficits that are known to afflict
ASD 17.
Interestingly, the fMRI signal complexity in
these RSNs were significantly (FDR q < 0.05) related to DNA methylation at
the CpG16 site of OXTR gene (Table 2: Fig. 1). ASD subjects with increased DNA
methylation levels exhibited less complexity (i.e., less synaptic noise) in brain function
networks. This indicates that higher DNA methylation level at CpG16 has a neuroprotective
effect on ASD.
Finally, the 48 IU dose of IN-OXT
significantly (FDR q < 0.05) reduced complexity at the long scales in a
number of brain RSNs that exhibited abnormally increased complexity described
above. This could indicates that the improvements in brain functional status in
ASD in response to OXT 5 could arise from increased inhibitory control that attenuates synaptic
noise in impaired brain function networks. Consistent with this notion, OXT has
been shown to affect GABA-mediated E/I control 6.CONCLUSION
The results from this study implicate disturbances in E/I
balance (due to increased synpatic noise potentially caused by synaptic pruning
deficits) in a number brain function networks incuding those subserving social
cognition and reward processing in ASD. OXT seems to attenuate the synaptic
noise and hence likely normalize E/I balance. The results also indicate that fMRI signal complexity measures like MSE could
act as diagnostic and therapeutic biomarkers of ASD.Acknowledgements
This
work was supported by NIH grants P50MH100023, ORIP/OD P51OD011132, and UL1TR002378;
as well as a pilot grant from Emory University Center for Mind, Brain, and
Culture.References
1. Arnold
Anteraper S, Guell X, D'Mello A, Joshi N, Whitfield-Gabrieli S, Joshi G.
Disrupted Cerebrocerebellar Intrinsic Functional Connectivity in Young Adults
with High-Functioning Autism Spectrum Disorder: A Data-Driven, Whole-Brain,
High-Temporal Resolution Functional Magnetic Resonance Imaging Study. Brain
Connect 2019;9:48-59.
2. Yarkoni
T, Poldrack RA, Nichols TE, Van Essen DC, Wager TD. Large-scale automated
synthesis of human functional neuroimaging data. Nat Methods 2011;8:665-70.
3. Foss-Feig
JH, Adkinson BD, Ji JL, et al. Searching for Cross-Diagnostic Convergence:
Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia
and Autism Spectrum Disorders. Biol Psychiatry 2017;81:848-61.
4. Yamasue
H, Domes G. Oxytocin and Autism Spectrum Disorders. Curr Top Behav Neurosci
2018;35:449-65.
5. Ooi
YP, Weng SJ, Kossowsky J, Gerger H, Sung M. Oxytocin and Autism Spectrum
Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled
Trials. Pharmacopsychiatry 2017;50:5-13.
6. Lopatina
OL, Komleva YK, Gorina YV, et al. Oxytocin and excitation/inhibition balance in
social recognition. Neuropeptides 2018;72:1-11.
7. Wang
DJJ, Jann K, Fan C, et al. Neurophysiological Basis of Multi-Scale Entropy of
Brain Complexity and Its Relationship With Functional Connectivity. Front
Neurosci 2018;12:352.
8. Smith
RX, Yan L, Wang DJ. Multiple time scale complexity analysis of resting state
FMRI. Brain Imaging Behav 2014;8:284-91.
9. McDonough
IM, Nashiro K. Network complexity as a measure of information processing across
resting-state networks: evidence from the Human Connectome Project. Front Hum
Neurosci 2014;8:409.
10. Maud
C, Ryan J, McIntosh JE, Olsson CA. The role of oxytocin receptor gene (OXTR)
DNA methylation (DNAm) in human social and emotional functioning: a systematic
narrative review. BMC Psychiatry 2018;18:154.
11. Andari
E, Nishitani S, Kaundinya G, et al. Epigenetic modification of the oxytocin
receptor gene: implications for autism symptom severity and brain functional
connectivity. Neuropsychopharmacology 2020;45:1150-8.
12. Pruim
RH, Mennes M, van Rooij D, Llera A, Buitelaar JK, Beckmann CF. ICA-AROMA: A
robust ICA-based strategy for removing motion artifacts from fMRI data.
Neuroimage 2015;112:267-77.
13. Craig
F, Margari F, Legrottaglie AR, Palumbi R, de Giambattista C, Margari L. A
review of executive function deficits in autism spectrum disorder and
attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat
2016;12:1191-202.
14. Levy
SE, Mandell DS, Schultz RT. Autism. Lancet 2009;374:1627-38.
15. Murphy
E, Benitez-Burraco A. Language deficits in schizophrenia and autism as related
oscillatory connectomopathies: An evolutionary account. Neurosci Biobehav Rev
2017;83:742-64.
16. Posar
A, Visconti P. Sensory abnormalities in children with autism spectrum disorder.
J Pediatr (Rio J) 2018;94:342-50.
17. Tang
G, Gudsnuk K, Kuo SH, et al. Loss of mTOR-dependent macroautophagy causes
autistic-like synaptic pruning deficits. Neuron 2014;83:1131-43.